Chandrabali Ghose is the founder and CEO of Bioharmony Therapeutics, an early-stage biotech startup specializing in the development of novel antimicrobials to combat drug-resistant bacterial infections. Chandra spent 8 years at the Aaron Diamond AIDS Research Center, an affiliate of Rockefeller University. Prior to that, Chandra was a postdoctoral fellow at Harvard Medical School. Chandra earned her PhD from New York University School of Medicine and her bachelor’s degree from Saint Louis University. She has published high-impact peer-reviewed articles and book chapters in the field of infectious diseases and has received many awards for her scientific and entrepreneurial contributions.